ReviewWorld journal of transplantation2025
Barriers to liver transplantation in the Arab world.
Review in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver transplantation is a vital intervention for patients with end-stage liver disease; however, the Arab world faces significant barriers that hinder access to this life-saving procedure in terms of both practice and research. This narrative review explores the multifaceted challenges, including financial constraints, limited healthcare infrastructure, cultural factors, and the prevalence of infectious diseases. In the Arab countries, both culture and religion were found to play major roles in the acceptability of liver transplantation. High rates of misconceptions and financial strain on patients and healthcare systems necessitate more transplantation programs and improved financial coverage and insurance policies. Enhancing healthcare facilities and improving access to innovative technologies through research is essential for optimizing transplantation outcomes, considering that common diseases in the region decrease the donor pool and increase complication risks. Public health initiatives to prevent and control prevalent liver diseases, particularly hepatitis, and to manage infection risk are also critical. Stricter regulations should be enforced in less developed countries in the region along with early screening practices to address inherited blood disorders and infectious diseases. Additionally, targeted research on liver diseases specific to the Arab context is crucial, along with fostering dialogue about cultural, religious, economic, and health-related factors affecting donor and recipient eligibility. By tackling these complex barriers through targeted comprehensive strategies, the Arab world can advance to a more equitable and effective liver transplantation system, ultimately improving patient outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.